<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">27438208</article-id>
      <article-id pub-id-type="pmc">4938285</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20163820</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Imported cutaneous leishmaniasis caused by Leishmania major in a
Chinese laborer who worked in Saudi Arabia<xref ref-type="fn" rid="fn1">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Zhang</surname>
            <given-names>Min</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Fang</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>Haibo</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Hu</surname>
            <given-names>Wenxing</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Sang</surname>
            <given-names>Hong</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label>Southern Medical University, Jinling Hospital - Nanjing,
China.</aff>
      <aff id="aff2"><label>2</label>Jinling Hospital affiliated to Nanjing University-
Nanjing, China.</aff>
      <author-notes>
        <corresp id="c1">Mailing address: Hong Sang Department of Dermatology Jinling
Hospital affiliated to Nanjing University 210002 Nanjing, China. E-mail:
<email>sanghong@nju.edu.cn</email></corresp>
        <fn fn-type="conflict">
          <p>Conflict of Interest: None.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>May-Jun</season>
        <year>2016</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>May-Jun</season>
        <year>2016</year>
      </pub-date>
      <volume>91</volume>
      <issue>3</issue>
      <fpage>365</fpage>
      <lpage>367</lpage>
      <history>
        <date date-type="received">
          <day>07</day>
          <month>7</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>13</day>
          <month>11</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2016 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2016</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the
Creative Commons Attribution Non-Commercial License which permits
unrestricted non-commercial use, distribution, and reproduction in any
medium provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>We report an imported case of cutaneous leishmaniasis in a 37-year-old man from
Saudi Arabia caused by Leishmania major. He presented with non-healing
nodulo-ulcerative lesions with a "volcanic crater" on the lower limbs. It was
clearly cutaneous leishmaniasis - a rare disease in China - as reflected by the
patient's clinical history, the lesions' morphology, histopathological
examination, culture and PCR analysis of the lesions. The patient was completely
cured after two cycles of sodium stibogluconate treatment. This case report
demonstrates that dermatologists should be aware of sporadic cutaneous
leishmaniasis cases in non-endemic areas.</p>
      </abstract>
      <kwd-group>
        <kwd>Leishmania major</kwd>
        <kwd>Leishmaniasis</kwd>
        <kwd>cutaneous</kwd>
        <kwd>Parasites</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>INTRODUTION</title>
      <p>Leishmaniasis, a major world health problem, is increasing in incidence because of
tourism and job-related travel<sup><xref rid="r1" ref-type="bibr">1</xref></sup>.
Depending on the Leishmania species and the host's immune status, different forms
may develop, including cutaneous leishmaniasis (CL), mucocutaneousleishmaniasis
(MCL) or visceral leishmaniasis (VL). About 90% of CL is endemic in the tropics and
neotropics, in countries such as Afghanistan, Algeria, Brazil, Iran, Peru, Saudi
Arabia and Syria<sup><xref rid="r2" ref-type="bibr">2</xref></sup>. Here we report a
case of CL acquired by a Chinese laborer who worked in Saudi Arabia.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>A 37-year-old, previously healthy man presented to our department with a non-healing
nodulo-ulcerative lesion for 3 months. The lesion started as a red papule and
developed into asymptomatic swelling within a few weeks and gradually extended.
Subsequently, the lesions became multiple, raised, well-defined, ulcerated,
developing into crusted nodules of variable size on the lower limbs (<xref ref-type="fig" rid="f1">Figure 1A</xref>). He worked on railroads in Saudi
Arabia for one year, beginning in September 2011, including night shifts.
Dermatological examination revealed multiple nodules in a zosteriform distribution
and several ulcerative or nodulo-ulcerative lesions with a "volcanic crater" on the
lower limbs (<xref ref-type="fig" rid="f1">Figure 1B</xref>). When he was
hospitalized, biopsies were taken. Histopathologic examination showed amastigotes in
histiocytes (<xref ref-type="fig" rid="f2">Figure 2A</xref> and <xref ref-type="fig" rid="f2">2B</xref>). Leishmaniasis was suspected, clinical samples for the
smears, and tissue were sent for polymerase chain reaction (PCR) analysis and
culture.</p>
      <p><fig id="f1" orientation="portrait" position="float"><label>Figure 1</label><caption><p><bold>A:</bold> Multiple nodules in a zosteriform distribution and an
ulcer on the left leg <bold>B</bold>: An ulcer with infiltrated border
and a satellite nodule on the right leg</p></caption><graphic xlink:href="abd-91-03-0365-g01"/></fig>
<fig id="f2" orientation="portrait" position="float"><label>Figure 2</label><caption><p>Histology of biopsy revealed amastigotes in histiocytes (A HE&#xD7;400,
B Wright stain&#xD7;400), (C) promastigotes were observed in
NNN-medium (Giemsa&#xD7;1000).</p></caption><graphic xlink:href="abd-91-03-0365-g02"/></fig></p>
      <p>Smears were fixed in methanol, Giemsa-stained, and microscopically examined for the
presence of amastigotes. Cultures were set up in the Novy-McNeal-Nicolle (NNN)
medium, and microscopically examined for promastigotes every 2 days. On day 10,
promastigotes were observed (<xref ref-type="fig" rid="f2">Figure 2C</xref>).
Further sequencing of the ITS-1 and ITS-2 PCR product showed 100% homology with
standard <italic>L. major</italic> (FM209179.1).</p>
      <p>The patient was diagnosed with CL based on the patient's clinical history,
thelesions' morphology, stained smear test, histopathological examination, culture
and PCR analysis.</p>
      <p>He was treated with intramuscular injections of sodium stibogluconate 600 mg/d for 10
days; the same treatment was repeated once more.As the lesions had signi&#xFB01;cantly
improved, the patient was discharged (<xref ref-type="fig" rid="f3">Figure 3A</xref>
and <xref ref-type="fig" rid="f3">3B</xref>). Post-treatment evaluation after 6
weeks, including direct microscopy, culture and PCR revealed no evidence of residual
disease. The patient was followed up for 2 years with no recurrence.</p>
      <p>
        <fig id="f3" orientation="portrait" position="float">
          <label>Figure 3</label>
          <caption>
            <p>Hyperpig - mented scars five months after the end of treatment(A and
B)</p>
          </caption>
          <graphic xlink:href="abd-91-03-0365-g03"/>
        </fig>
      </p>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>Cutaneous Leishmaniasis was first described by Moursy in Saudi Arabia in
1976.<sup><xref rid="r3" ref-type="bibr">3</xref></sup>It is recognized as a
complex and highly variable disease in terms of its epidemiology, etiology,
pathology and clinical presentation. It can be caused by several
<italic>Leishmaniaspp</italic>, entailing the major species of <italic>L.
tropica</italic> and <italic>L. major</italic> in the Old World, and <italic>L.
infantum</italic>, <italic>L. amazonensis, L.mexicana</italic> and
<italic>L.venezuelensis</italic> in the New World.<sup><xref rid="r1" ref-type="bibr">1</xref></sup> In endemic countries, it occurs more often in
children than in adults. The most frequently affected sites are the face and
extremities. CL typically presents as papules, crusted nodules, plaques, or
nodulo-ulcerative lesions.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> CL
lesions may simulate other conditions such as tumor-like lesions, when ulcerated,
they may resemble basal cell carcinomas, especially in older individuals, making
diagnosis dif&#xFB01;cult. To maximize sensitivity and speci&#xFB01;city of diagnosis,
examinations including direct microscopy, histopathology, culture and PCR should
ideally be performed.</p>
      <p>In China, CL induced by <italic>L. infantum</italic> only occurred in Karamay, Xin
jiang, with a prevalence of 1.0-1.6%. Our patient represented a rare case of
imported CL induced by <italic>L. major</italic> whilst working in Saudi Arabia.
According to the literature, CL caused by <italic>L. major</italic> is a growing,
endemic, public health problem in many parts of the Kingdom of Saudi
Arabia.<sup><xref rid="r4" ref-type="bibr">4</xref></sup> Most of patients
reported were non-Saudi expatriate workers who <bold>suffered</bold> mostly from
multiple and severely in&#xFB02;amed nodulo-ulcerative lesions on exposed body parts. The
vector is Phlebotomuspapatasi and desert rodents are the main animal reservoirs. But
CL can represent a diagnostic challenge in non-endemic areas where experience is
limited.</p>
      <p>Treatment aims to accelerate healing, reduce the risk of scarring and prevent disease
progression. The choice of treatment depends on lesion size and location, the number
of lesions and the potential for dissemination. Pentavalent, antimonial drugs
(sodium stibogluconate or meglumineantimonate) are the traditionally accepted
&#xFB01;rst-line agents. Miltefosine<sup><xref rid="r5" ref-type="bibr">5</xref></sup> has
recently emerged as an agent to treat leishmaniasis, offering signi&#xFB01;cant advantages
like good oral bioavailability and tolerability. Using intravenous liposomal
amphotericin B, Harefuah successfully treated CL in a 1-year-old boy with multiple
skin lesions, free of complications.<sup><xref rid="r6" ref-type="bibr">6</xref></sup> Other successful therapies such as azithromycin, fluconazole and
itraconazole have also been reported. <sup><xref rid="r7" ref-type="bibr">7</xref>-<xref rid="r9" ref-type="bibr">9</xref></sup></p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other" id="fn1">
        <label>*</label>
        <p>Work performed at the Department of Dermatology, Southern Medical University,
Jinling Hospital - Nanjing, China.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ameen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous and mucocutaneousleishmaniasis: emerging therapies and
progress in disease management</article-title>
          <source>Expert OpinPharmacother</source>
          <year>2010</year>
          <volume>11</volume>
          <fpage>557</fpage>
          <lpage>569</lpage>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ameen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis: advances in disease pathogenesis,
diagnostics and therapeutics</article-title>
          <source>Clin ExpDermatol</source>
          <year>2010</year>
          <volume>35</volume>
          <fpage>699</fpage>
          <lpage>705</lpage>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Morsy</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Shoura</surname>
              <given-names>MI</given-names>
            </name>
          </person-group>
          <article-title>Some aspects of cutaneous leishmaniasis in Riyadh</article-title>
          <source>J Trop Med Hyg</source>
          <year>1976</year>
          <volume>79</volume>
          <fpage>137</fpage>
          <lpage>139</lpage>
          <pub-id pub-id-type="pmid">950683</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Al-Tawfiq</surname>
              <given-names>JA</given-names>
            </name>
            <name>
              <surname>AbuKhamsin</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis: a 46-year study of the epidemiology and
clinical features in Saudi Arabia (1956-2002)</article-title>
          <source>Int J Infect Dis</source>
          <year>2004</year>
          <volume>8</volume>
          <fpage>244</fpage>
          <lpage>250</lpage>
          <pub-id pub-id-type="pmid">15234329</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dorlo</surname>
              <given-names>TP</given-names>
            </name>
            <name>
              <surname>van Thiel</surname>
              <given-names>PP</given-names>
            </name>
            <name>
              <surname>Schoone</surname>
              <given-names>GJ</given-names>
            </name>
            <name>
              <surname>Stienstra</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>van Vugt</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Beijnen</surname>
              <given-names>JH</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Dynamics of parasite clearance in cutaneous leishmaniasis
patients treated with miltefosine</article-title>
          <source>PloSNeglTrop Dis</source>
          <year>2011</year>
          <volume>5</volume>
          <elocation-id/>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ben-Shimol</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sagi</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Schwartz</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Greenberg</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <chapter-title>Cutaneous leishmaniasis treated with ambisome
(liposomalamphotericin B)</chapter-title>
          <source>Harefuah</source>
          <year>2012</year>
          <volume>151</volume>
          <fpage>458</fpage>
          <lpage>498</lpage>
          <page-range>458-60, 498</page-range>
          <pub-id pub-id-type="pmid">23350289</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Salisbury</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Jones</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Higgins</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Vega-Lopez</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis: three children with Leishmania major
successfully treated with itraconazole</article-title>
          <source>Pediatr Dermatol</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>78</fpage>
          <lpage>80</lpage>
          <pub-id pub-id-type="pmid">16445420</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sklavos</surname>
              <given-names>AV</given-names>
            </name>
            <name>
              <surname>Walls</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Webber</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Watson</surname>
              <given-names>AB</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis in a child treated with oral
fluconazole</article-title>
          <source>Australas J Dermatol</source>
          <year>2010</year>
          <volume>51</volume>
          <fpage>195</fpage>
          <lpage>197</lpage>
          <pub-id pub-id-type="pmid">20695859</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Minodier</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Zambelli</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Mary</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Faraut</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Garnier</surname>
              <given-names>JM</given-names>
            </name>
            <name>
              <surname>Berbis</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Cutaneous leishmaniasis treated with azithromycin in a
child</article-title>
          <source>Pediatr Infect Dis J</source>
          <year>2008</year>
          <volume>27</volume>
          <fpage>80</fpage>
          <lpage>81</lpage>
          <pub-id pub-id-type="pmid">18162948</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
